Related Experiment Videos
Insulin resistance in dilated cardiomyopathy
Ankur Shah1, Richard P Shannon
1Cardiovascular Research Institute and Department of Medicine, Allegheny General Hospital, Pittsburgh, Pennsylvania, USA.
Reviews in Cardiovascular Medicine
|December 12, 2003
Summary
Insulin resistance is common in advanced dilated cardiomyopathy, impairing the heart's ability to use glucose for energy. This finding suggests new therapeutic strategies targeting insulin resistance in heart failure.
Area of Science:
- Cardiology
- Metabolic Research
- Biochemistry
Background:
- Advanced dilated cardiomyopathy is associated with insulin resistance.
- The failing heart relies on glucose oxidation for energy production.
- Efficient glucose metabolism is crucial for maintaining cardiac function.
Purpose of the Study:
- To investigate the link between insulin resistance and dilated cardiomyopathy.
- To explore the mechanisms underlying impaired glucose metabolism in heart failure.
- To provide a rationale for therapeutic interventions targeting insulin resistance.
Main Methods:
- Evidence of insulin resistance in dilated cardiomyopathy was assessed.
- The relationship between insulin resistance and sympathetic nervous system activation was explored.
- Alterations in the insulin signaling cascade were examined in relation to lipolysis.
Main Results:
- Insulin resistance was confirmed in advanced dilated cardiomyopathy.
- Increased sympathetic nervous system activation and lipolysis were observed.
- The insulin signaling cascade showed alterations contributing to impaired cardiac metabolism.
Conclusions:
- Insulin resistance significantly impacts energy production in the failing heart.
- Understanding these metabolic changes is crucial for developing new treatments.
- Targeting insulin resistance may offer a novel therapeutic approach for dilated cardiomyopathy.